Pricing Log in Create free account

Aditxt, Inc. (ADTX) vs Nuvilex Inc. (PMCB)

Aditxt, Inc. and Nuvilex Inc. are both Biotechnology companies. Aditxt, Inc. and Nuvilex Inc. are of similar size ($4.4M and $4.0M). Nuvilex Inc. grew revenue faster over the last twelve months: −71.1% against −74.2%. Nuvilex Inc. has the higher net margin (0.00% vs −372,998.6%) and the higher return on invested capital (0.00% vs 0.00%). Across the 12 metrics below, Nuvilex Inc. leads on 7 and Aditxt, Inc. on 5.

Valuation

Metric ADTX PMCB Biotechnology median
P/E n/m n/m 10.60
P/S n/m n/m 9.40
P/B n/m 0.14 2.13
Price to free cash flow n/m n/m 25.18
EV/EBITDA n/m 3.77 0.66
EV/Sales 73.26 n/m 9.02
Earnings yield 0.00% (650.59%) (32.88%)
Free cash flow yield 0.00% (266.52%) (23.13%)

Profitability

Metric ADTX PMCB Biotechnology median
Gross margin 20.28% 95.64% 68.51%
Operating margin (128,143.36%) 0.00% 0.00%
Net margin (372,998.60%) 0.00% 0.00%
Free cash flow margin (129,979.72%) 0.00% 0.00%
Return on equity 549.59% (58.04%) (51.96%)
Return on assets (236.38%) (50.43%) (46.06%)
Return on invested capital 0.00% 0.00% 0.00%

Growth

Metric ADTX PMCB Biotechnology median
Revenue growth (TTM) (74.19%) (71.06%) 6.76%
EPS growth (last fiscal year) 99.96% (186.83%) 29.88%
Revenue growth, 5-year CAGR — — 9.75%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric ADTX PMCB Biotechnology median
Debt to equity 0.00 0.00 0.00
Current ratio 0.06 40.29 4.97
Net debt to EBITDA 0.18 5.41 1.01

Dividend

Metric ADTX PMCB Biotechnology median
Dividend yield — — 0.41%
Payout ratio — — —

Size

Metric ADTX PMCB Biotechnology median
Market cap 4.39m 4.03m 161.82m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack